These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 27789587)

  • 1. Expression of miR-18a and miR-210 in Normal Breast Tissue as Candidate Biomarkers of Breast Cancer Risk.
    Shidfar A; Costa FF; Scholtens D; Bischof JM; Sullivan ME; Ivancic DZ; Vanin EF; Soares MB; Wang J; Khan SA
    Cancer Prev Res (Phila); 2017 Jan; 10(1):89-97. PubMed ID: 27789587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
    Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
    Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study.
    Moi L; Braaten T; Al-Shibli K; Lund E; Busund LR
    J Transl Med; 2019 Oct; 17(1):334. PubMed ID: 31581940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and biological impact of miR-18a expression in breast cancer after neoadjuvant chemotherapy.
    Luengo-Gil G; García-Martínez E; Chaves-Benito A; Conesa-Zamora P; Navarro-Manzano E; González-Billalabeitia E; García-Garre E; Martínez-Carrasco A; Vicente V; Ayala de la Peña F
    Cell Oncol (Dordr); 2019 Oct; 42(5):627-644. PubMed ID: 31115881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort.
    Godfrey AC; Xu Z; Weinberg CR; Getts RC; Wade PA; DeRoo LA; Sandler DP; Taylor JA
    Breast Cancer Res; 2013 May; 15(3):R42. PubMed ID: 23705859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer.
    McDermott AM; Miller N; Wall D; Martyn LM; Ball G; Sweeney KJ; Kerin MJ
    PLoS One; 2014; 9(1):e87032. PubMed ID: 24498016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of lipid metabolism genes and PBX1 in the contralateral breasts of women with estrogen receptor-negative breast cancer.
    Wang J; Shidfar A; Ivancic D; Ranjan M; Liu L; Choi MR; Parimi V; Gursel DB; Sullivan ME; Najor MS; Abukhdeir AM; Scholtens D; Khan SA
    Int J Cancer; 2017 Jun; 140(11):2484-2497. PubMed ID: 28263391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-1290 and its potential targets are associated with characteristics of estrogen receptor α-positive breast cancer.
    Endo Y; Toyama T; Takahashi S; Yoshimoto N; Iwasa M; Asano T; Fujii Y; Yamashita H
    Endocr Relat Cancer; 2013 Feb; 20(1):91-102. PubMed ID: 23183268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Relevance of microRNA Expressions in Breast Cancer Validated Using the Cancer Genome Atlas (TCGA).
    Kim SY; Kawaguchi T; Yan L; Young J; Qi Q; Takabe K
    Ann Surg Oncol; 2017 Oct; 24(10):2943-2949. PubMed ID: 28766230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
    Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
    BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers.
    van Schooneveld E; Wouters MC; Van der Auwera I; Peeters DJ; Wildiers H; Van Dam PA; Vergote I; Vermeulen PB; Dirix LY; Van Laere SJ
    Breast Cancer Res; 2012 Feb; 14(1):R34. PubMed ID: 22353773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
    Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
    J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidating the Role of MicroRNA-18a in Propelling a Hybrid Epithelial-Mesenchymal Phenotype and Driving Malignant Progression in ER-Negative Breast Cancer.
    Nair MG; Mavatkar AD; Naidu CM; V P S; C E A; Rajarajan S; Sahoo S; Mohan G; Jaikumar VS; Ramesh RS; B S S; Jolly MK; Maliekal TT; Prabhu JS
    Cells; 2024 May; 13(10):. PubMed ID: 38786043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.
    Liu WH; Yeh SH; Lu CC; Yu SL; Chen HY; Lin CY; Chen DS; Chen PJ
    Gastroenterology; 2009 Feb; 136(2):683-93. PubMed ID: 19027010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer.
    Thakur S; Grover RK; Gupta S; Yadav AK; Das BC
    PLoS One; 2016; 11(7):e0158946. PubMed ID: 27404381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer.
    Yoshimoto N; Toyama T; Takahashi S; Sugiura H; Endo Y; Iwasa M; Fujii Y; Yamashita H
    Breast Cancer Res Treat; 2011 Nov; 130(1):331-9. PubMed ID: 21755340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA and LncRNA Expression Profiles in Human Estrogen Receptor Positive Breast Cancer.
    Shao X; Huang P; Shi L; Lei L; Cao W; Chen Z; Wang X; Zheng Y
    Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of miRNA expression profiling in surgical pathology materials, with Ki-67, HER2, ER and PR in breast cancer patients.
    Sakurai M; Masuda M; Miki Y; Hirakawa H; Suzuki T; Sasano H
    Int J Biol Markers; 2015 May; 30(2):e190-9. PubMed ID: 25907662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?
    Cizeron-Clairac G; Lallemand F; Vacher S; Lidereau R; Bieche I; Callens C
    BMC Cancer; 2015 Jul; 15():499. PubMed ID: 26141719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.